bluebird bio, Inc. (0HOH.L)
USD 9.28
(33.91%)
USD 9.28
(33.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 29.49 Million | 3.59 Million | 3.66 Million | 250.73 Million | 44.67 Million | 54.57 Million |
| Cost of Revenue | 33.52 Million | 10.07 Million | 38.85 Million | 5.39 Million | 2.97 Million | 885 Thousand |
| Gross Profit | -4.03 Million | -6.48 Million | -35.19 Million | 245.33 Million | 41.69 Million | 53.69 Million |
| Operating Expenses | 240.23 Million | 275.67 Million | 529.91 Million | 874.85 Million | 853.77 Million | 622.71 Million |
| Selling, General and Administrative Expenses | 165.51 Million | 136.9 Million | 209.96 Million | 286.89 Million | 271.36 Million | 174.12 Million |
| Research and Development Expenses | 167.65 Million | 240.76 Million | 319.94 Million | 587.95 Million | 582.41 Million | 448.58 Million |
| Other Expenses | -92.93 Million | -102 Million | 27.65 Million | -6.5 Million | -10.08 Million | 1.96 Million |
| Cost and Expenses | 273.75 Million | 285.74 Million | 568.77 Million | 880.24 Million | 856.75 Million | 623.6 Million |
| Operating Income | -244.26 Million | -287.09 Million | -590.91 Million | -629.51 Million | -812.07 Million | -572.02 Million |
| Interest Expense | 16.35 Million | 6.32 Million | - | - | 34.76 Million | 14.62 Million |
| Income Tax Expense | -126 Thousand | 117 Thousand | 258 Thousand | 686 Thousand | -545 Thousand | 187 Thousand |
| Earnings before Tax | -212.03 Million | -266.46 Million | -562.38 Million | -618 Million | -790.15 Million | -555.43 Million |
| Net Income | -211.91 Million | -266.57 Million | -562.63 Million | -618.69 Million | -789.6 Million | -555.62 Million |
| Earnings Per Share Basic | -1.93 | -3.39 | -8.16 | -9.95 | -14.31 | -10.68 |
| Earnings Per Share Diluted | -1.93 | -3.39 | -8.16 | -9.95 | -14.31 | -10.68 |
| Weighted Average Shares Outstanding | 109.82 Million | 78.58 Million | 68.91 Million | 62.17 Million | 55.19 Million | 52.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 109.82 Million | 78.58 Million | 68.91 Million | 62.17 Million | 55.19 Million | 52.03 Million |
| Gross Margin | -0.14 | -1.80 | -9.61 | 0.98 | 0.93 | 0.98 |
| EBIT Margin | -5.67 | -77.07 | -147.27 | -2.54 | -18.12 | -10.37 |
| Profit Margin | -7.18 | -74.11 | -153.64 | -2.47 | -17.67 | -10.18 |
| EBITDA | -167.16 Million | -215.55 Million | -556.92 Million | -553.63 Million | -772.71 Million | -551.86 Million |
| Earnings Before Tax Margin | -8.28 | -79.81 | -161.36 | -2.51 | -18.18 | -10.48 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.1 Million | 18.57 Million | 7.83 Million | 29.49 Million | 12.39 Million | 6.89 Million |
| Cost of Revenue | 28.94 Million | 25.86 Million | 9.63 Million | 33.52 Million | 10.95 Million | 9.56 Million |
| Gross Profit | -12.84 Million | -7.29 Million | -1.79 Million | -4.03 Million | 1.43 Million | -2.67 Million |
| Operating Expenses | 75.54 Million | 71.4 Million | 80.87 Million | 240.23 Million | 86.16 Million | 82.62 Million |
| Selling, General and Administrative Expenses | 50.38 Million | 46.32 Million | 47.1 Million | - | 40.7 Million | 40.34 Million |
| Research and Development Expenses | 25.16 Million | 25.07 Million | 33.77 Million | - | 45.46 Million | 42.27 Million |
| Other Expenses | 9.63 Million | 11.16 Million | 8.55 Million | 38.7 Million | 10.54 Million | 9.63 Million |
| Cost and Expenses | 104.49 Million | 97.26 Million | 90.5 Million | 273.75 Million | 97.12 Million | 92.18 Million |
| Operating Income | -88.39 Million | -78.69 Million | -82.67 Million | -244.26 Million | -84.72 Million | -85.29 Million |
| Interest Expense | 5.45 Million | 4.85 Million | - | 16.35 Million | - | - |
| Income Tax Expense | 21 Thousand | 16.02 Million | -46 Thousand | -126 Thousand | -3.52 Million | -80 Thousand |
| Earnings before Tax | -81.37 Million | -69.8 Million | -88.56 Million | -212.03 Million | -71.73 Million | -72.98 Million |
| Net Income | -81.39 Million | -69.8 Million | -88.51 Million | -211.91 Million | -71.73 Million | -72.9 Million |
| Earnings Per Share Basic | -0.42 | -0.36 | -0.75 | - | -0.66 | -0.67 |
| Earnings Per Share Diluted | -0.42 | -0.36 | -0.75 | - | -0.66 | -0.67 |
| Weighted Average Shares Outstanding | 193.71 Million | 193.15 Million | 118.53 Million | 109.82 Million | 109.09 Million | 108.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 193.71 Million | 193.15 Million | 118.53 Million | 109.82 Million | 109.09 Million | 108.68 Million |
| Gross Margin | -0.80 | -0.39 | -0.23 | -0.14 | 0.12 | -0.39 |
| EBIT Margin | -3.69 | -2.66 | -1.11 | - | -6.84 | -12.24 |
| Profit Margin | -5.06 | -3.76 | -11.30 | -7.18 | -5.79 | -10.58 |
| EBITDA | -59.39 Million | -49.47 Million | -8.69 Million | - | -84.72 Million | -84.32 Million |
| Earnings Before Tax Margin | -5.49 | -4.24 | -10.55 | -8.28 | -6.84 | -12.38 |
BIOEX
GXI
MKKGY
5821
GEN
7965